{"city":"San Jose","name":"Procept BioRobotics","slug":"procept-biorobotics","facts":[{"date":"2026-04-01","type":"revenue_band","value":"[object Object]","source":"Procept IR"},{"date":"2026-04-01","type":"revenue","value":"Q1-2026 revenue growth","source":"Procept IR"}],"peers":[{"name":"Intuitive Surgical","rank":1,"slug":"intuitive-surgical","score":"100"},{"name":"Stryker","rank":29,"slug":"stryker","score":"86"},{"name":"Zimmer Biomet","rank":60,"slug":"zimmer-biomet","score":"81"},{"name":"Smith+Nephew","rank":65,"slug":"smith-nephew","score":"81"}],"stage":"Established","state":"California","aliases":[],"country":"United States","domains":[{"why":"Procept BioRobotics develops and sells robotic surgical systems for urologic procedures, including the AquaBeam Robotic System for waterjet ablation in benign prostatic hyperplasia treatment.","list":"Robotics 100","rank":88,"tier":"member","layer":"Systems","total":78,"domain":"Robotics","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":8,"commercial":8,"deployment":8,"production":8,"technology":8},"edition":"November 2026","segment":"Medical & surgical"}],"founded":null,"signals":[{"date":"2026-10-01","header":"Investors filed a securities class-action lawsuit against PROCEPT BioRobotics.","outlet":"PR Newswire, all releases"},{"date":"2026-09-22","header":"Class action lawsuit filed against PROCEPT BioRobotics Corporation","outlet":"PR Newswire, all releases"},{"date":"2026-09-15","header":"Investors with losses can lead securities fraud class action against PROCEPT VinRobotics Corporation","outlet":"PR Newswire, all releases"},{"date":"2026-09-12","header":"PROCEPT BioRobotics Corporation faces a securities fraud class action tied to undisclosed inventory issues and an approximately 18% stock decline.","outlet":"PR Newswire, all releases"},{"date":"2026-09-12","header":"Investors in PROCEPT BioRobotics securities litigation have until September 22, 2026 to apply as lead plaintiff.","outlet":"PR Newswire, all releases"},{"date":"2026-09-10","header":"A securities class action was filed against PROCEPT BioRobotics Corporation.","outlet":"PR Newswire, all releases"}],"website":"procept-biorobotics.com","category":"Robotics · Systems","categories":[{"name":"Medical & surgical","domain":"Robotics","parent":"Robotics · Systems"}],"last_round":null,"updated_at":"2026-10-25T23:18:47.108753+00:00","facts_total":2,"positioning":"Procept BioRobotics is a US surgical-robotics maker whose Aquablation system runs about 12,200 US procedures a quarter, with FY26 guidance of $390-410M (+27-33%). It gained FDA clearance for its second-generation FirstAssist AI in Q1-26, an EAU guideline recommending Aquablation over TURP, and its first UK Hydros units at ASPs above $400k. It is not yet profitable (Q1-26 net loss widened to $31.6M), with adjusted-EBITDA breakeven targeted for Q4-26.","sub_category":"Medical & surgical","signals_total":9,"url":"https://www.frontiertechintelligence.com/companies/procept-biorobotics","title":"Procept BioRobotics · robotics, San Jose, California, United States · scores, facts and signals · Frontier Tech Intelligence","description":"Procept BioRobotics develops and sells robotic surgical systems for urologic procedures, including the AquaBeam Robotic System for waterjet ablation in benign prostatic hyperplasia treatment. Robotics 100 rank 88 (score 78) 9 signals and 2 facts with sources.","publisher":"Frontier Tech Intelligence (Future Frontiers, a trade name of Essential Cognition Inc.)","note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}